Global Vascular Closure Devices Market 2016-2020 - Product Image

Global Vascular Closure Devices Market 2016-2020

  • ID: 3784844
  • Report
  • Region: Global
  • 69 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardinal Health
  • Essential Medical
  • Medeon Biodesign
  • St. Jude Medical
  • Vascular Closure Systems
  • MORE
About the Vascular Closure Devices Market

The global vascular closure devices market is likely to grow at a steady pace during the forecast period. This is because many clinical studies regarding vascular closure devices raised concerns about their safety and efficacy profiles. In many clinical cases, manual compressions were used as vascular closure devices that failed to show their efficacy. Vascular closure devices are used for both diagnostic and therapeutic interventions.

Concerns regarding these devices have led vendors to invest extensively in their R&D. These devices help in the diagnosis and treatment of cardiac diseases. A rise in the incidence of these diseases will lead to the demand and sales of vascular closure devices. The sales will further increase with the rapid adoption of minimally invasive equipment for cardiac surgeries. Minimally invasive surgeries such as angiography cause less pain, minimize infections, and help reduce hospital stay.

The analysts forecast the global vascular closure devices market to grow at a CAGR of 8.67% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global vascular closure devices market for 2016-2020. To calculate the market size, the analyst considers the revenue generated from the sales of vascular closure devices used for arteriotomy site closure after cardiac catheterization.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Vascular Closure Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Cardinal Health
- St. Jude Medical
- Vascular Solutions

Other prominent vendors
- Arstasis
- Beijing Puyishengji Medical Technology
- Endocor
- Essential Medical
- InSeal Medical
- Medeon Biodesign
- Morrris Innovative
- Transluminal Technologies
- Vascular Closure Systems
- Vasorum
- Vivasure Medical

Market drivers
- Minimally invasive procedures with improved medical imaging
- For a full, detailed list, view the full report

Market challenges
- Complications of vascular closure devices
- For a full, detailed list, view the full report

Market trends
- Popularity of robot-assisted catheterization for PCI
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardinal Health
  • Essential Medical
  • Medeon Biodesign
  • St. Jude Medical
  • Vascular Closure Systems
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
  • Femoral artery access for cardiac catheterization
  • Radial artery access for cardiac catheterization
PART 05: Impact of comparative study on manual compression and vascular closure device
  • Clinical studies to compare vascular closure devices to manual compression devices
PART 06: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 07: Market segmentation by product
  • Global vascular closure devices market for active approximators
  • Global vascular closure devices market for passive approximators
PART 08: Market segmentation by application
  • Diagnostic intervention
  • Therapeutic intervention
PART 09: Market segmentation by end-user
  • ASCs
  • Hospitals
  • Physicians' offices
PART 10: Geographical segmentation
  • Vascular closure devices market in Americas
  • Vascular closure devices market in EMEA
  • Vascular closure devices market in APAC
PART 11: Market drivers
  • Incidence of cardiac diseases and adoption of interventional cardiac catheterization
  • Minimally invasive procedures with improved medical imaging
  • Popularity of femoral arterial cardiac catheterization
PART 12: Impact of drivers

PART 13: Market challenges
  • High cost of vascular closure devices and reimbursement issues
  • Complications of vascular closure devices
  • Non-invasive CT angiography
PART 14: Impact of drivers and challenges

PART 15: Market trends
  • Popularity of robot-assisted catheterization for PCI
  • Emergence of digital cath labs in hospitals
  • Novel technologies to improve patient comfort
PART 16: Vendor landscape
  • Competitive scenario
  • Market ranking
PART 17: Major vendors
  • Abbott Laboratories
  • Cardinal Health
  • St. Jude Medical
  • Vascular Solutions
  • Other prominent vendors
PART 18: Appendix
  • List of abbreviations
PART 19: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Clinical trials on vascular closure devices compared with manual compression devices
Exhibit 03: Global vascular closure devices market segmentation
Exhibit 04: Global vascular closure devices market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global vascular closure devices market segmentation by product 2015
Exhibit 07: Global vascular closure devices market segmentation by product 2020
Exhibit 08: Different types of vascular closure devices for clinical practices
Exhibit 09: Global vascular closure devices market for active approximators 2015-2020 ($ billions)
Exhibit 10: Global vascular closure devices market for passive approximators 2015-2020 ($ millions)
Exhibit 11: Trends in diagnostic intervention
Exhibit 12: Trends in therapeutic intervention
Exhibit 13: Global vascular closure devices market segmentation by end-user 2015
Exhibit 14: Global vascular closure devices market segmentation by geography 2015
Exhibit 15: Global vascular closure devices market segmentation by geography 2020
Exhibit 16: Global vascular closure devices market segmentation by geography 2015-2020
Exhibit 17: Global vascular closure devices market segmentation by geography 2015-2020 ($ millions)
Exhibit 18: Vascular closure devices market in Americas 2015-2020 ($ millions)
Exhibit 19: Comparison of US healthcare system: Before and after reforms
Exhibit 20: Implements amended in ACA
Exhibit 21: Number of coronary revascularization procedures per 100,000 people in EMEA 2013
Exhibit 22: Number of coronary angiography procedures in few countries in EMEA 2006 and 2013
Exhibit 23: Vascular closure devices market in EMEA 2015-2020 ($ millions)
Exhibit 24: Vascular closure devices market in APAC 2015-2020 ($ millions)
Exhibit 25: China: GDP 2010-2014 ($ trillions)
Exhibit 26: China: Healthcare expenditure 2009-2013 (% of GDP)
Exhibit 27: Impact of drivers
Exhibit 28: Impact of drivers and challenges
Exhibit 29: Global vascular closure devices market: Competitive landscape 2015
Exhibit 30: Ranking of vendors that develop active approximators 2015
Exhibit 31: Ranking of vendors that develop passive approximators 2015
Exhibit 32: Abbott Laboratories: Metrics analysis
Exhibit 33: Cardinal Health: Metrics analysis
Exhibit 34: St. Jude Medical: Metrics analysis
Exhibit 35: Vascular Solutions: Metrics analysis
Exhibit 36: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardinal Health
  • Essential Medical
  • Medeon Biodesign
  • St. Jude Medical
  • Vascular Closure Systems
  • MORE
New Report Released: – Global Vascular Closure Devices Market 2016-2020

The author of the report recognizes the following companies as the key players in the global vascular closure devices market: Abbott Laboratories, Cardinal Health, St. Jude Medical, and Vascular Solutions.

Other Prominent Vendors in the market are: Arstasis, Beijing Puyishengji Medical Technology, Endocor, Essential Medical, InSeal Medical, Medeon Biodesign, Morrris Innovative, Transluminal Technologies, Vascular Closure Systems, Vasorum, and Vivasure Medical.

Commenting on the report, an analyst from the research team said: “A key trend which is boosting market growth is the popularity of robot-assisted catheterization for percutaneous coronary intervention (PCI). Physicians are using robot-assisted catheterization technology to improve the performance of minimally invasive and less invasive procedures. The technology helps enhance vascular puncture and improve patient care. Robot-assisted procedures can reduce hospital stays and facilitate cost management. Moreover, the rising awareness of these benefits of robot-assisted catheterization among people and physicians has led many hospitals and clinics to install them.”

According to the report, a key growth driver in the market is the growing use of minimally invasive surgeries along with MRI technology. Medical facilities worldwide are shifting toward minimally invasive procedure that involve the use of radiotherapy and imaging technologies, expanding the treatment options for peripheral vascular diseases (PVD) such as deep vein thrombosis. Physicians use angioplasty or insert stents in the blood vessels through small incisions by minimally invasive surgeries. These procedures help minimize trauma and pain and reduces the risks of infection in the blood vessels.

Further, the report states that a major factor that could hamper market growth is the several complications associated with vascular closure devices. Vascular closure devices after coronary angioplasty helps in early hemostasis and improved ambulation. However, arterial puncture involved with vascular closure devices can cause some complications. The intravascular component of these devices can also cause thrombosis, which can lead to limb ischemia. The insertion of vascular closure devices through femoral arterial cardiac catheterization can cause retroperitoneal hemorrhage.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Cardinal Health
- St. Jude Medical
- Vascular Solutions
- Arstasis
- Beijing Puyishengji Medical Technology
- Endocor
- Essential Medical
- InSeal Medical
- Medeon Biodesign
- Morrris Innovative
- Transluminal Technologies
- Vascular Closure Systems
- Vasorum
- Vivasure Medical.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll